Becton, Dickinson and Company Company Profile (NYSE:BDX)

About Becton, Dickinson and Company (NYSE:BDX)

Becton, Dickinson and Company logoBecton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. BD Medical consists of various business units, including diabetes care, medication and procedural solutions, medication management solutions and pharmaceutical systems. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. The Company's BD Life Sciences segment consists of various business units, including preanalytical systems, diagnostic systems and biosciences.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Supplies
  • Sub-Industry: Health Care Equipment
  • Symbol: NYSE:BDX
  • CUSIP: 07588710
  • Web: www.bd.com
Capitalization:
  • Market Cap: $46.22758 billion
  • Outstanding Shares: 213,305,000
Average Prices:
  • 50 Day Moving Avg: $195.21
  • 200 Day Moving Avg: $184.45
  • 52 Week Range: $161.29 - $205.73
P/E:
  • Trailing P/E Ratio: 34.10
  • Foreward P/E Ratio: 19.72
  • P/E Growth: 2.16
Sales & Book Value:
  • Annual Revenue: $12.32 billion
  • Price / Sales: 3.55
  • Book Value: $37.33 per share
  • Price / Book: 5.50
Dividend:
  • Annual Dividend: $2.92
  • Dividend Yield: 1.4%
Profitability:
  • EBIDTA: $3.2 billion
  • Net Margins: 10.67%
  • Return on Equity: 25.37%
  • Return on Assets: 7.92%
Debt:
  • Debt-to-Equity Ratio: 1.14%
  • Current Ratio: 1.22%
  • Quick Ratio: 0.78%
Misc:
  • Average Volume: 2.01 million shs.
  • Beta: 1.05
  • Short Ratio: 4.32
 
Frequently Asked Questions for Becton, Dickinson and Company (NYSE:BDX)

What is Becton, Dickinson and Company's stock symbol?

Becton, Dickinson and Company trades on the New York Stock Exchange (NYSE) under the ticker symbol "BDX."

How often does Becton, Dickinson and Company pay dividends? What is the dividend yield for Becton, Dickinson and Company?

Becton, Dickinson and Company announced a quarterly dividend on Tuesday, May 23rd. Investors of record on Friday, June 9th will be given a dividend of $0.73 per share on Friday, June 30th. This represents a $2.92 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date of this dividend is Wednesday, June 7th. View Becton, Dickinson and Company's Dividend History.

How were Becton, Dickinson and Company's earnings last quarter?

Becton, Dickinson and Company (NYSE:BDX) posted its quarterly earnings data on Tuesday, May, 2nd. The company reported $2.30 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $2.23 by $0.07. The company had revenue of $2.97 billion for the quarter, compared to analyst estimates of $2.92 billion. Becton, Dickinson and Company had a return on equity of 25.37% and a net margin of 10.67%. The business's revenue for the quarter was down 3.2% on a year-over-year basis. During the same period in the previous year, the firm earned $2.18 EPS. View Becton, Dickinson and Company's Earnings History.

When will Becton, Dickinson and Company make its next earnings announcement?

Becton, Dickinson and Company is scheduled to release their next quarterly earnings announcement on Thursday, August, 3rd 2017. View Earnings Estimates for Becton, Dickinson and Company.

What guidance has Becton, Dickinson and Company issued on next quarter's earnings?

Becton, Dickinson and Company issued an update on its FY17 earnings guidance on Tuesday, May, 2nd. The company provided EPS guidance of $9.35-9.45 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $9.44. The company issued revenue guidance of decline 3.5-4% YoY to $12.0-12.06 billion, compared to the consensus revenue estimate of $12.05 billion.

Where is Becton, Dickinson and Company's stock going? Where will Becton, Dickinson and Company's stock price be in 2017?

11 brokers have issued 1 year target prices for Becton, Dickinson and Company's stock. Their predictions range from $165.00 to $230.00. On average, they expect Becton, Dickinson and Company's share price to reach $191.91 in the next twelve months. View Analyst Ratings for Becton, Dickinson and Company.

What are analysts saying about Becton, Dickinson and Company stock?

Here are some recent quotes from research analysts about Becton, Dickinson and Company stock:

  • 1. According to Zacks Investment Research, "Becton, Dickinson and Company, popularly known as BD, is steadily moving towards its announced acquisition of medical technology player, C. R. Bard. The $24 billion transaction is slated to be completed in the fourth quarter. Post completion of the acquisition, BD expects growth in adjusted earnings starting fiscal 2019. We believe the acquisition to be a strategic fit and would generate benefits from complementary businesses and geographical expansion. Becton's cost-control initiatives are also noteworthy. On the flipside, unfavorable sales performance from the BD Medical segment is a concern. Also, adverse foreign exchange is likely to pose major headwinds for the rest of the fiscal. Furthermore, the company had an unfavorable run on the bourse over the last three months, trading significantly below the broader industry." (7/17/2017)
  • 2. Citigroup Inc. analysts commented, "We see a diminishing impact on growth from emerging markets, which once contributed over 50 percent of total growth for the company but will likely only contribute about one third of total growth going forward, and as an aside we're slightly cautious on the timing of O-US synergy benefits from CFN. The extra burden will shift to developed markets," (9/23/2016)

Who are some of Becton, Dickinson and Company's key competitors?

Who are Becton, Dickinson and Company's key executives?

Becton, Dickinson and Company's management team includes the folowing people:

  • Vincent A. Forlenza, Chairman of the Board, Chief Executive Officer
  • Thomas E. Polen, President
  • Christopher R. Reidy, Chief Financial Officer, Executive Vice President, Chief Administrative Officer
  • Linda M. Tharby, Chief Human Resource Officer, Executive Vice President
  • Nabil Shabshab, Executive Vice President - Strategic Planning Chief Marketing Officer
  • Jeffrey S. Sherman, Executive Vice President, General Counsel
  • Gary M. Cohen, Executive Vice President and President - Global Health.
  • Alexandre Conroy, Executive Vice President and President, Europe, EMA
  • James Lim, Executive Vice President and President, Greater Asia
  • Alberto Mas, Executive Vice President and President - Life Sciences Segment

Who owns Becton, Dickinson and Company stock?

Becton, Dickinson and Company's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Jarislowsky Fraser Ltd (0.40%), APG Asset Management N.V. (0.29%), Rockefeller Financial Services Inc. (0.23%), BTIM Corp. (0.21%), SPF Beheer BV (0.17%) and Waverton Investment Management Ltd (0.16%). Company insiders that own Becton, Dickinson and Company stock include Ellen R Strahlman, Gary M Cohen, James C Lim, James F Orr, Jeffrey S Sherman, Jerome V Hurwitz, John E Gallagher, Linda M Tharby, Nabil Shabshab, Rebecca W Rimel, Stephen Sichak, Thomas E Polen Jr, Vincent A Forlenza and William A Kozy. View Institutional Ownership Trends for Becton, Dickinson and Company.

Who sold Becton, Dickinson and Company stock? Who is selling Becton, Dickinson and Company stock?

Becton, Dickinson and Company's stock was sold by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, Jarislowsky Fraser Ltd, AMI Asset Management Corp, Huntington National Bank, LS Investment Advisors LLC, Catawba Capital Management VA, Exxonmobil Investment Management Inc. TX and Assenagon Asset Management S.A.. Company insiders that have sold Becton, Dickinson and Company stock in the last year include Gary M Cohen, Jeffrey S Sherman, John E Gallagher, Linda M Tharby and Stephen Sichak. View Insider Buying and Selling for Becton, Dickinson and Company.

Who bought Becton, Dickinson and Company stock? Who is buying Becton, Dickinson and Company stock?

Becton, Dickinson and Company's stock was bought by a variety of institutional investors in the last quarter, including Waverton Investment Management Ltd, Rockefeller Financial Services Inc., Mn Services Vermogensbeheer B.V., Atalanta Sosnoff Capital LLC, Aperio Group LLC, NN Investment Partners Holdings N.V., M. Kraus & Co and Pennsylvania Trust Co. View Insider Buying and Selling for Becton, Dickinson and Company.

How do I buy Becton, Dickinson and Company stock?

Shares of Becton, Dickinson and Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Becton, Dickinson and Company's stock price today?

One share of Becton, Dickinson and Company stock can currently be purchased for approximately $205.30.


MarketBeat Community Rating for Becton, Dickinson and Company (NYSE BDX)
Community Ranking:  2.0 out of 5 ( )
Outperform Votes:  249 (Vote Outperform)
Underperform Votes:  370 (Vote Underperform)
Total Votes:  619
MarketBeat's community ratings are surveys of what our community members think about Becton, Dickinson and Company and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Becton, Dickinson and Company (NYSE:BDX) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 3 Hold Ratings, 6 Buy Ratings, 1 Strong Buy Rating
Consensus Rating:Buy (Score: 2.64)
Consensus Price Target: $191.91 (6.52% downside)

Analysts' Ratings History for Becton, Dickinson and Company (NYSE:BDX)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/21/2017Bank of America CorporationReiterated RatingBuy$200.00 -> $225.00MediumView Rating Details
7/10/2017Cowen and CompanyReiterated RatingOutperform$200.00 -> $230.00LowView Rating Details
6/30/2017Raymond James Financial, Inc.UpgradeOutperform -> Strong-Buy$210.00 -> $180.00LowView Rating Details
4/24/2017Evercore ISIUpgradeIn-Line -> Outperform$186.00 -> $200.00HighView Rating Details
4/13/2017Royal Bank Of CanadaReiterated RatingHold$177.00LowView Rating Details
3/29/2017Jefferies Group LLCReiterated RatingBuy$200.00LowView Rating Details
1/3/2017J P Morgan Chase & CoDowngradeOverweight -> Neutral$190.00 -> $175.00N/AView Rating Details
11/21/2016Leerink SwannReiterated RatingMarket Perform$180.00 -> $185.00N/AView Rating Details
11/4/2016Deutsche Bank AGReiterated RatingBuy$197.00 -> $189.00N/AView Rating Details
10/21/2016ArgusReiterated RatingBuy$185.00N/AView Rating Details
9/23/2016Citigroup Inc.DowngradeNeutral -> Sell$167.00 -> $165.00N/AView Rating Details
5/8/2016Morgan StanleyReiterated RatingHoldN/AView Rating Details
4/8/2016Goldman Sachs Group, Inc. (The)Boost Price Target$156.00 -> $157.00N/AView Rating Details
11/22/2015Piper Jaffray CompaniesReiterated RatingOverweight$160.00 -> $171.00N/AView Rating Details
11/19/2015William BlairReiterated RatingOutperformN/AView Rating Details
(Data available from 7/22/2015 forward)

Earnings

Earnings History for Becton, Dickinson and Company (NYSE:BDX)
Earnings by Quarter for Becton, Dickinson and Company (NYSE:BDX)
Earnings History by Quarter for Becton, Dickinson and Company (NYSE BDX)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/3/2017$2.44N/AView Earnings Details
5/2/2017Q2 2017$2.23$2.30$2.92 billion$2.97 billionViewListenView Earnings Details
2/2/2017Q117$2.11$2.33$2.86 billion$2.92 billionViewListenView Earnings Details
11/3/2016Q416$2.09$2.12$3.22 billion$3.23 billionViewListenView Earnings Details
8/4/2016Q316$2.20$2.35$3.21 billion$3.20 billionViewListenView Earnings Details
5/5/2016Q216$2.02$2.18$3.07 billion$3.07 billionViewListenView Earnings Details
2/3/2016Q116$1.84$1.96$3.04 billion$2.99 billionViewListenView Earnings Details
11/4/2015Q415$1.90$1.94$3.04 billion$3.07 billionViewListenView Earnings Details
8/6/2015Q315$2.01$2.05$3.13 billion$3.12 billionViewListenView Earnings Details
5/7/2015Q2$1.54$1.61$2.05 billion$2.05 billionViewListenView Earnings Details
2/5/2015Q115$1.43$1.53$2.04 billion$2.05 billionViewListenView Earnings Details
11/4/2014Q414$1.65$1.68$2.16 billion$2.20 billionViewListenView Earnings Details
7/31/2014Q314$1.68$1.68$2.14 billion$2.16 billionViewListenView Earnings Details
5/1/2014Q2$1.50$1.53$2.09 billion$2.07 billionViewListenView Earnings Details
2/4/2014Q114$1.30$1.42$1.98 billion$2.00 billionViewListenView Earnings Details
11/5/2013Q413$1.46$1.52$2.05 billion$2.10 billionViewListenView Earnings Details
8/1/2013Q3 2013$1.48$1.58$2.05 million$2.05 billionViewListenView Earnings Details
5/2/2013Q2 2013$1.35$1.44$1.99 billion$2.00 billionViewListenView Earnings Details
2/5/2013Q1 2013$1.24$1.35$1.86 billion$1.90 billionViewListenView Earnings Details
11/7/2012Q412$1.40$1.42$1.96 billion$1.97 billionViewN/AView Earnings Details
8/2/2012$1.53$1.52ViewN/AView Earnings Details
5/1/2012$1.38$1.38ViewN/AView Earnings Details
2/7/2012$1.17$1.21ViewN/AView Earnings Details
11/2/2011$1.41$1.39ViewN/AView Earnings Details
8/2/2011$1.43$1.53ViewN/AView Earnings Details
4/26/2011$1.30$1.38ViewN/AView Earnings Details
2/7/2011$1.29$1.35ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Becton, Dickinson and Company (NYSE:BDX)
2017 EPS Consensus Estimate: $9.09
2018 EPS Consensus Estimate: $10.23
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$2.06$2.10$2.08
Q2 20172$2.20$2.23$2.22
Q3 20172$2.44$2.46$2.45
Q4 20172$2.34$2.35$2.35
Q1 20181$2.28$2.28$2.28
Q2 20181$2.42$2.42$2.42
Q3 20181$2.81$2.81$2.81
Q4 20181$2.72$2.72$2.72
(Data provided by Zacks Investment Research)

Dividends

Current Dividend Information for Becton, Dickinson and Company (NYSE:BDX)
Most Recent Dividend:6/30/2017
Annual Dividend:$2.92
Dividend Yield:1.42%
Dividend Growth:10.10% (3 Year Average)
Payout Ratio:48.26% (Trailing 12 Months of Earnings)
30.90% (Based on This Year's Estimates)
28.05% (Based on Next Year's Estimates)
Track Record:45 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Becton, Dickinson and Company (NYSE:BDX)

Dividend History by Quarter for Becton, Dickinson and Company (NYSE BDX)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/23/2017quarterly$0.731.56%6/7/20176/9/20176/30/2017
1/23/2017quarterly$0.731.71%3/8/20173/10/20173/31/2017
11/21/2016quarterly$0.731.74%12/7/201612/9/201612/30/2016
7/26/2016quarterly$0.661.51%9/7/20169/9/20169/30/2016
5/24/2016quarterly$0.661.58%6/7/20166/9/20166/30/2016
1/25/2016quarterly$0.661.81%3/8/20163/10/20163/31/2016
11/23/2015quarterly$0.661.75%12/8/201512/10/201512/31/2015
7/28/2015quarterly$0.601.58%9/4/20159/9/20159/30/2015
5/19/2015quarterly$0.601.69%6/5/20156/9/20156/30/2015
1/27/2015quarterly$0.601.65%3/6/20153/10/20153/31/2015
11/25/2014quarterly$0.601.7%12/8/201412/10/201412/31/2014
7/22/2014quarterly$0.551.84%9/5/20149/9/20149/30/2014
5/20/2014quarterly$0.551.88%6/5/20146/9/20146/30/2014
1/28/2014quarterly$0.552.02%3/6/20143/10/20143/31/2014
11/26/2013quarterly$0.552%12/6/201312/10/201312/31/2013
7/23/2013quarterly$0.501.91%9/5/20139/9/20139/30/2013
5/21/2013quarterly$0.501.98%6/5/20136/7/20136/28/2013
1/29/2013quarterly$0.502.35%3/6/20133/8/20133/29/2013
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Becton, Dickinson and Company (NYSE:BDX)
Insider Ownership Percentage: 1.40%
Institutional Ownership Percentage: 75.42%
Insider Trades by Quarter for Becton, Dickinson and Company (NYSE:BDX)
Institutional Ownership by Quarter for Becton, Dickinson and Company (NYSE:BDX)
Insider Trades by Quarter for Becton, Dickinson and Company (NYSE:BDX)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/25/2017Jeffrey S ShermanVPSell28,765$185.98$5,349,714.70View SEC Filing  
2/15/2017Jeffrey S ShermanVPSell31,464$180.02$5,664,149.28View SEC Filing  
12/15/2016John E GallagherVPSell1,793$168.82$302,694.26View SEC Filing  
12/5/2016Stephen SichakInsiderSell2,632$164.44$432,806.08View SEC Filing  
11/4/2016Stephen SichakInsiderSell10,352$176.10$1,822,987.20View SEC Filing  
9/6/2016Linda M TharbyInsiderSell11,704$177.27$2,074,768.08View SEC Filing  
8/11/2016Gary M CohenInsiderSell29,367$176.81$5,192,379.27View SEC Filing  
6/13/2016John E GallagherVPSell1,931$169.87$328,018.97View SEC Filing  
6/7/2016Nabil ShabshabEVPSell5,080$168.75$857,250.00View SEC Filing  
5/17/2016Jeffrey S ShermanVPSell34,373$166.27$5,715,198.71View SEC Filing  
5/13/2016Stephen SichakEVPSell12,995$166.48$2,163,407.60View SEC Filing  
5/13/2016Vincent A ForlenzaCEOSell37,933$166.17$6,303,326.61View SEC Filing  
5/10/2016James F OrrDirectorSell1,368$167.66$229,358.88View SEC Filing  
5/9/2016James C LimEVPSell5,257$165.60$870,559.20View SEC Filing  
5/6/2016Ellen R StrahlmanSVPSell3,019$163.52$493,666.88View SEC Filing  
5/6/2016Jerome V HurwitzEVPSell3,878$163.58$634,363.24View SEC Filing  
5/6/2016Rebecca W RimelDirectorSell684$163.69$111,963.96View SEC Filing  
12/14/2015Stephen SichakEVPSell8,670$152.21$1,319,660.70View SEC Filing  
12/9/2015William A KozyEVPSell15,495$154.43$2,392,892.85View SEC Filing  
12/8/2015Vincent A. ForlenzaCEOSell17,762$153.10$2,719,362.20View SEC Filing  
12/7/2015Jeffrey S ShermanVPSell7,586$153.76$1,166,423.36View SEC Filing  
12/1/2015Thomas E Polen JrEVPSell2,683$152.21$408,379.43View SEC Filing  
11/30/2015John E GallagherVPSell1,600$150.70$241,120.00View SEC Filing  
11/18/2015Jerome V. HurwitzEVPSell2,347$151.02$354,443.94View SEC Filing  
6/1/2015Stephen SichakEVPSell12,188$140.94$1,717,776.72View SEC Filing  
5/22/2015Thomas E Polen JrEVPSell3,882$142.56$553,417.92View SEC Filing  
5/21/2015Linda M TharbyEVPSell6,069$142.02$861,919.38View SEC Filing  
5/20/2015William A KozyEVPSell10,326$142.00$1,466,292.00View SEC Filing  
5/19/2015William A KozyEVPSell10,435$142.01$1,481,874.35View SEC Filing  
5/18/2015Bertram L ScottDirectorSell2,160$141.74$306,158.40View SEC Filing  
5/18/2015James C LimEVPSell3,604$141.80$511,047.20View SEC Filing  
5/15/2015Alexandre ConroyEVPSell1,291$141.37$182,508.67View SEC Filing  
5/13/2015Jeffrey S ShermanVPSell10,983$138.40$1,520,047.20View SEC Filing  
5/11/2015Jerome V HurwitzEVPSell1,197$141.43$169,291.71View SEC Filing  
5/8/2015Gary M CohenEVPSell13,490$142.90$1,927,721.00View SEC Filing  
6/12/2014Stephen SichakSVPSell1,456$118.25$172,172.00View SEC Filing  
6/10/2014Gary M CohenEVPSell12,476$119.24$1,487,638.24View SEC Filing  
6/9/2014Jeffrey S ShermanVPSell7,877$120.24$947,130.48View SEC Filing  
3/6/2014Jeffrey ShermanVPSell1,303$115.16$150,053.48View SEC Filing  
11/12/2013William KozyEVPSell9,597$108.30$1,039,355.10View SEC Filing  
11/11/2013Jeffrey ShermanVPSell4,272$107.78$460,436.16View SEC Filing  
11/11/2013Jerome HurwitzSVPSell1,151$107.78$124,054.78View SEC Filing  
11/8/2013Vincent ForlenzaCEOSell32,411$107.39$3,480,617.29View SEC Filing  
11/6/2013Henry Becton, Jr.DirectorSell2,276$106.77$243,008.52View SEC Filing  
8/23/2013Bertram ScottDirectorSell4,047$98.61$399,074.67View SEC Filing  
8/8/2013Edward DegraanDirectorSell4,436$100.03$443,733.08View SEC Filing  
8/8/2013Stephen SichakSVPSell3,431$100.13$343,546.03View SEC Filing  
8/7/2013Basil AndersonDirectorSell2,160$99.79$215,546.40View SEC Filing  
5/22/2013Henry P Becton JrDirectorSell3,117$101.86$317,497.62View SEC Filing  
5/17/2013Donna M BolesVPSell2,415$101.38$244,832.70View SEC Filing  
5/13/2013Gary M CohenEVPSell8,753$100.22$877,225.66View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Becton, Dickinson and Company (NYSE:BDX)
Latest Headlines for Becton, Dickinson and Company (NYSE:BDX)
Source:
DateHeadline
finance.yahoo.com logoWhat Drove JNJ’s 2Q17 Results
finance.yahoo.com - July 21 at 6:04 PM
americanbankingnews.com logoJefferies Group Comments on Becton, Dickinson and Company's Q4 2017 Earnings (BDX)
www.americanbankingnews.com - July 21 at 1:19 PM
americanbankingnews.com logoBank of America Corporation Reaffirms Buy Rating for Becton, Dickinson and Company (BDX)
www.americanbankingnews.com - July 21 at 9:30 AM
seekingalpha.com logoBecton, Dickinson In The Garden Portfolio - Seeking Alpha
seekingalpha.com - July 20 at 5:59 PM
americanbankingnews.com logoBecton, Dickinson and Company (BDX) to Post FY2017 Earnings of $9.43 Per Share, Jefferies Group Forecasts
www.americanbankingnews.com - July 20 at 10:35 AM
streetinsider.com logoBecton Dickinson (BDX) Granted FDA 510(k) Clearance for New Immunological Diagnostic System
www.streetinsider.com - July 19 at 10:42 PM
streetinsider.com logoBecton Dickinson (BDX) Granted FDA 510(k) Clearance for New Immunological Diagnostic System - StreetInsider.com
www.streetinsider.com - July 19 at 5:41 PM
finance.yahoo.com logoBD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
finance.yahoo.com - July 19 at 5:41 PM
finance.yahoo.com logoBD Transforms Microbiology Urine Testing
finance.yahoo.com - July 18 at 5:55 PM
americanbankingnews.com logoContrasting AngioDynamics (ANGO) and Becton, Dickinson and Company (BDX)
www.americanbankingnews.com - July 14 at 10:29 PM
americanbankingnews.com logoReviewing Becton, Dickinson and Company (NYSE:BDX) & AngioDynamics (ANGO)
www.americanbankingnews.com - July 14 at 12:54 PM
americanbankingnews.com logo$3.06 Billion in Sales Expected for Becton, Dickinson and Company (NYSE:BDX) This Quarter
www.americanbankingnews.com - July 13 at 1:20 PM
finance.yahoo.com logoBehind BD’s Recent New Stock Price High
finance.yahoo.com - July 11 at 5:30 PM
americanbankingnews.com logoZacks: Analysts Anticipate Becton, Dickinson and Company (BDX) to Announce $2.44 Earnings Per Share
www.americanbankingnews.com - July 11 at 9:38 AM
bizjournals.com logoTissue Diagnostic Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016 - 2024
www.bizjournals.com - July 11 at 4:30 AM
prnewswire.com logoGlobal Automated and Rapid Microbiological Tests - Biotechnology
www.prnewswire.com - July 11 at 4:29 AM
finance.yahoo.com logoWhich BD Product Launches Will Drive the Most Growth?
finance.yahoo.com - July 10 at 4:28 PM
finance.yahoo.com logoInside the Latest BD Collaborations and Growth Accelerators
finance.yahoo.com - July 10 at 4:28 PM
finance.yahoo.com logoHow Attractive Is BD’s Dividend?
finance.yahoo.com - July 10 at 4:28 PM
americanbankingnews.com logoBecton, Dickinson and Company's (NYSE:BDX) Outperform Rating Reaffirmed at Cowen and Company
www.americanbankingnews.com - July 10 at 3:04 PM
finance.yahoo.com logoTop Analyst Reports for Procter & Gamble, Verizon & Citigroup
finance.yahoo.com - July 8 at 9:08 AM
finance.yahoo.com logoBD Announces Live Webcast of Third Fiscal Quarter Earnings Conference Call
finance.yahoo.com - July 6 at 5:48 PM
americanbankingnews.com logoCritical Analysis: AngioDynamics (ANGO) and Becton, Dickinson and Company (BDX)
www.americanbankingnews.com - July 6 at 12:34 AM
americanbankingnews.com logoAnalyzing Becton, Dickinson and Company (NYSE:BDX) & AngioDynamics (ANGO)
www.americanbankingnews.com - July 4 at 8:16 PM
finance.yahoo.com logoETFs with exposure to Becton, Dickinson & Co. : June 30, 2017
finance.yahoo.com - June 30 at 4:32 PM
americanbankingnews.com logoBecton, Dickinson and Company (BDX) Upgraded to "Strong-Buy" by Raymond James Financial, Inc.
www.americanbankingnews.com - June 30 at 11:00 AM
finance.yahoo.com logoWhat Drove Becton, Dickinson (BDX) to a New 52-Week High?
finance.yahoo.com - June 28 at 4:35 PM
americanbankingnews.com logoBecton, Dickinson and Company (BDX) Given Average Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - June 27 at 8:43 AM
americanbankingnews.com logoBecton, Dickinson and Company (BDX) and AngioDynamics (ANGO) Head to Head Survey
www.americanbankingnews.com - June 25 at 8:06 PM
americanbankingnews.com logoHead to Head Analysis: AngioDynamics (ANGO) & Becton, Dickinson and Company (BDX)
www.americanbankingnews.com - June 24 at 4:40 PM
seekingalpha.com logoBecton, Dickinson: A Quality Dividend Aristocrat With Double-Digit Payout Growth
seekingalpha.com - June 22 at 11:45 AM
finance.yahoo.com logoCorporate News Blog - BD Receives FDA 501(k) Clearance for Snowden-Pencer 3.00 mm Laparoscopic Instruments
finance.yahoo.com - June 22 at 11:45 AM
nasdaq.com logoYieldBoost Becton, Dickinson & Co From 1.5% To 9.9% Using Options - Nasdaq
www.nasdaq.com - June 21 at 4:52 PM
prnewswire.com logoBD Receives FDA 510(k) Clearance for New Line of Customizable, 3.0mm Micro-Laparoscopic Instruments - PR Newswire (press release)
www.prnewswire.com - June 21 at 2:41 AM
finance.yahoo.com logoBD Receives FDA 510(k) Clearance for New Line of Customizable, 3.0mm Micro-Laparoscopic Instruments
finance.yahoo.com - June 20 at 4:34 PM
finance.yahoo.com logoETFs with exposure to Becton, Dickinson & Co. : June 20, 2017
finance.yahoo.com - June 20 at 4:34 PM
finance.yahoo.com logoBecton, Dickinson & Co. :BDX-US: Earnings Analysis: Q2, 2017 By the Numbers : June 19, 2017
finance.yahoo.com - June 19 at 4:00 PM
americanbankingnews.com logoZacks: Brokerages Expect Becton, Dickinson and Company (BDX) Will Post Quarterly Sales of $3.06 Billion
www.americanbankingnews.com - June 17 at 11:46 AM
americanbankingnews.com logoBecton, Dickinson and Company (BDX) Expected to Announce Earnings of $2.44 Per Share
www.americanbankingnews.com - June 15 at 8:40 AM
finance.yahoo.com logoSteven Cohen Bullish on Health Care Sector
finance.yahoo.com - June 14 at 9:05 PM
finance.yahoo.com logoFlowJo and BD to Provide Cloud Platform for Real-Time Single-Cell Marketing Collaboration
finance.yahoo.com - June 13 at 1:07 PM
finance.yahoo.com logoKaon Interactive Wins Three Awards at DxMA Global Marketing Summit
finance.yahoo.com - June 12 at 4:53 PM
streetinsider.com logoBecton Dickinson (BDX) Announce Second Request for Additional Information from FTC in Connection with Pending ... - StreetInsider.com
www.streetinsider.com - June 10 at 2:28 AM
reuters.com logoBRIEF-Becton Dickinson & Co and Bard get second requests from ftc under Hart-Scott-Rodino Act
www.reuters.com - June 9 at 9:27 PM
finance.yahoo.com logoBecton, Dickinson & Co. : BDX-US: Dividend Analysis : June 09th, 2017 (record date) : By the numbers : June 8, 2017
finance.yahoo.com - June 8 at 4:40 PM
nasdaq.com logoBecton, Dickinson and Company (BDX) Ex-Dividend Date Scheduled for June 07, 2017 - Nasdaq
www.nasdaq.com - June 6 at 4:03 PM
streetinsider.com logoBecton Dickinson (BDX) Granted FDA 510(K) Clearance for ... - StreetInsider.com
www.streetinsider.com - June 5 at 3:41 PM
nasdaq.com logoEx-Dividend Reminder: Anthem, Becton, Dickinson and Weyerhaeuser
www.nasdaq.com - June 5 at 12:50 PM
finance.yahoo.com logoBD Announces Extension of Exchange Offers and Consent Solicitations for C. R. Bard, Inc. Notes
finance.yahoo.com - June 5 at 12:50 PM
finance.yahoo.com logoBD Receives FDA 510(K) Clearance for Molecular Test for Harmful Intestinal Bacteria Causing Infectious Diarrhea
finance.yahoo.com - June 5 at 12:50 PM

Social

Chart

Becton, Dickinson and Company (BDX) Chart for Saturday, July, 22, 2017

This page was last updated on 7/22/2017 by MarketBeat.com Staff